Reader Comments
Post a new comment on this article
Post Your Discussion Comment
Please follow our guidelines for comments and review our competing interests policy. Comments that do not conform to our guidelines will be promptly removed and the user account disabled. The following must be avoided:
- Remarks that could be interpreted as allegations of misconduct
- Unsupported assertions or statements
- Inflammatory or insulting language
Thank You!
Thank you for taking the time to flag this posting; we review flagged postings on a regular basis.
closeVitamin D contributes to the immune response to type A influenza
Posted by wbgrant on 02 Jul 2012 at 18:45 GMT
The paper by Pawelek et al. [1] discussed the roles of both adaptive and innate immune responses in response to influenza infection. While the model was based on the innate immune response by type I interferon, it was mentioned that other cytokines might also be involved.
I would like to point out that vitamin D makes important contributions to the innate response against type A influenza. The ultraviolet-B-vitamin D-influenza hypothesis was proposed by John Cannell and colleagues based on the seasonality of epidemic influenza [2]. The role of vitamin D in reducing risk of influenza was supported in a randomized controlled trial involving African-American women in the United States [3]. It was also supported by a randomized controlled trial involving school children in Japan [4]. An observational study found significantly reduced risk of acute respiratory infections for serum 25-hydroxyvitamin D concentrations above 38 ng/ml [5].
It was also found in an ecological study of the 1918-19 pandemic influenza that communities with higher solar UVB doses had lower influenza case-fatality rates [6]. The reasons for this finding were attributed to a reduced cytokine storm in response to the type AH1N1 infection as well as induction of cathelicidin to combat the ensuing bacterial infection.
The results from [1] might be extended through a model involving the effects of vitamin D.
Disclosure
I receive funding from the UV Foundation (McLean, VA), Bio-Tech Pharmacal (Fayetteville, AR), the Vitamin D Council (San Luis Obispo, CA), the Vitamin D Society (Canada), and the Sunlight Research Forum (Veldhoven).
References
1. Pawelek KA, Huynh GT, Quinlivan M, Cullinane A, Rong L, et al. (2012) Modeling within-host dynamics of influenza virus infection including immune responses. PLoS Comput Biol 8(6): e1002588. doi:10.1371/journal.pcbi.1002588
2. Cannell JJ, Vieth R, Umhau JC, Holick MF, Grant WB, et al. (2006) Epidemic influenza and vitamin D. Epidemiol Infect. 134(6):1129-40.
3.Aloia JF, Li-Ng M. (2007) Re: epidemic influenza and vitamin D. Epidemiol Infect. 135(7):1095-6; author reply 1097-8.
4. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, et al. (2010) Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 91(5):1255-60.
5. Sabetta JR, DePetrillo P, Cipriani RJ, Smardin J, Burns LA, et al. (2010) Serum 25-hydroxyvitamin D and the incidence of acute viral respiratory tract infections in healthy adults. PLoS One. 5(6):e11088.
6. Grant WB, Giovannucci E. (2009) The possible roles of solar ultraviolet-B radiation and vitamin D in reducing case-fatality rates from the 1918–1919 influenza pandemic in the United States. Dermatoendocrinol. 1(4): 215-9.